The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst like Arthur He from HC Wainwright & Co. is likely to instill confidence among investors and could positively influence LAVA Therapeutics' stock price in the short term. Analyst ratings, especially from well-regarded firms, often impact investor sentiment and can lead to price movements.